73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Novel combination of antibodies leads to significant improvement in cancer immunotherapy

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons
Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

by Julia Evangelou Strait,Washington University School of MedicineA small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who r

Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

by Julia Evangelou Strait,Washington University School of MedicineA small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who r
Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

byUniversity of LiverpoolCredit: CC0 Public DomainTreating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery,

Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

byUniversity of LiverpoolCredit: CC0 Public DomainTreating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery,
Cancer screening and detection remain below prepandemic levels

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in&

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in&
FDA approves Abecma for relapsed, refractory multiple myeloma

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.
Mutations in donors' stem cells may cause problems for cancer patients

Mutations in donors' stem cells may cause problems for cancer patients

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis suggests that bone marrow -- or blood stem cells -- from healthy donors can harbo

Mutations in donors' stem cells may cause problems for cancer patients

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis suggests that bone marrow -- or blood stem cells -- from healthy donors can harbo
Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

by University of TsukubaCredit: Unsplash/CC0 Public DomainAllogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord bloo

Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

by University of TsukubaCredit: Unsplash/CC0 Public DomainAllogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord bloo
Patient-centered clinical guideline on partial breast irradiation for early-stage invasive breast cancer and DCIS

Patient-centered clinical guideline on partial breast irradiation for early-stage invasive breast cancer and DCIS

by American Society for Radiation OncologyAdjuvant Radiation Therapy Treatment Options for Early-Stage Invasive Breast Cancer or DCISAbbreviations: DCIS = ductal carcinoma in situ; ER = estrogen

Patient-centered clinical guideline on partial breast irradiation for early-stage invasive breast cancer and DCIS

by American Society for Radiation OncologyAdjuvant Radiation Therapy Treatment Options for Early-Stage Invasive Breast Cancer or DCISAbbreviations: DCIS = ductal carcinoma in situ; ER = estrogen
'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

by Aslan Mansurov,The ConversationDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors. Credit:Victor Segura Ibarra and Rita Serda/National

'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

by Aslan Mansurov,The ConversationDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors. Credit:Victor Segura Ibarra and Rita Serda/National
Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

by Kavli IPMUFigure 1. The radionuclide-encapsulated liposomes, including the focus of the study, a ligand called ethylenedicysteine (EC). Credit: Umeda et alA team of researchers has developed a new

Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

by Kavli IPMUFigure 1. The radionuclide-encapsulated liposomes, including the focus of the study, a ligand called ethylenedicysteine (EC). Credit: Umeda et alA team of researchers has developed a new
New research finds oral leukemia therapy to work as well as intravenous decitabine

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival